- Home
- FBIOP vs PFIS Comparison
FBIOP vs PFIS Comparison
Compare FBIOP & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- PFIS
- Stock Information
- Founded
- FBIOP N/A
- PFIS 1905
- Country
- FBIOP United States
- PFIS United States
- Employees
- FBIOP 101
- PFIS N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- PFIS Major Banks
- Sector
- FBIOP Health Care
- PFIS Finance
- Exchange
- FBIOP Nasdaq
- PFIS Nasdaq
- Market Cap
- FBIOP N/A
- PFIS N/A
- IPO Year
- FBIOP N/A
- PFIS N/A
- Fundamental
- Price
- FBIOP $8.41
- PFIS $51.23
- Analyst Decision
- FBIOP
- PFIS
- Analyst Count
- FBIOP 0
- PFIS 0
- Target Price
- FBIOP N/A
- PFIS N/A
- AVG Volume (30 Days)
- FBIOP N/A
- PFIS 30.5K
- Earning Date
- FBIOP N/A
- PFIS 07-24-2025
- Dividend Yield
- FBIOP N/A
- PFIS 4.80%
- EPS Growth
- FBIOP N/A
- PFIS N/A
- EPS
- FBIOP N/A
- PFIS 2.14
- Revenue
- FBIOP N/A
- PFIS $138,502,000.00
- Revenue This Year
- FBIOP N/A
- PFIS $66.02
- Revenue Next Year
- FBIOP N/A
- PFIS $4.37
- P/E Ratio
- FBIOP N/A
- PFIS $24.02
- Revenue Growth
- FBIOP N/A
- PFIS 43.82
- 52 Week Low
- FBIOP N/A
- PFIS $38.90
- 52 Week High
- FBIOP N/A
- PFIS $59.70
- Technical
- Relative Strength Index (RSI)
- FBIOP 56.06
- PFIS 55.35
- Support Level
- FBIOP $7.82
- PFIS $52.17
- Resistance Level
- FBIOP $8.60
- PFIS $53.08
- Average True Range (ATR)
- FBIOP 0.45
- PFIS 1.25
- MACD
- FBIOP -0.01
- PFIS 0.19
- Stochastic Oscillator
- FBIOP 80.73
- PFIS 61.85
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.